Glyn Owain Edwards
Director/Board Member bei Summit Therapeutics Ltd.
Profil
Glyn Owain Edwards is currently a Non-Executive Director at Summit Therapeutics Ltd., a Director at The National Cancer Research Institute, a Non-Executive Director at OxSonics Ltd., a Director at Summit (Oxford) Ltd., and a Director at OrthoSon Ltd.
Previously, he served as the Chief Executive Officer of Antisoma Research Ltd.
from 1998 to 2011, the Chief Executive Officer & Executive Director of Sarossa Capital Ltd.
from 2010 to 2011, the Chief Executive Officer of The Bioindustry Association from 2011 to 2012, the Chief Executive Officer & Director of Summit Therapeutics, Inc., a Director of Discuva Ltd., and the Vice President-Business Development of Therapeutic Antibodies Ltd.
Mr. Edwards completed his undergraduate studies at the University of Bristol and his graduate studies at London Business School.
Aktive Positionen von Glyn Owain Edwards
Unternehmen | Position | Beginn |
---|---|---|
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 26.02.2020 |
The National Cancer Research Institute
The National Cancer Research Institute Miscellaneous Commercial ServicesCommercial Services The National Cancer Research Institute (NCRI) is an organization that focuses on advancing cancer research with the input of cancer patients and carers. The non-profit company is based in London, UK. The British company collects research funding data to understand how money is distributed across various areas of research and identify any gaps. NCRI is creating a research-ready workforce, strengthening the retention of early career researchers and facilitating the early interaction of clinical and preclinical researchers. The company aims to deliver better outcomes for those affected by cancer by identifying gaps in research and addressing them. | Director/Board Member | - |
OxSonics Ltd.
OxSonics Ltd. Hospital/Nursing ManagementHealth Services OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - |
Summit (Oxford) Ltd.
Summit (Oxford) Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2019, Summit (Oxford) Ltd. is a subsidiary of Summit Therapeutics, Inc. that engages in the discovery and development of novel drugs. The private company is based in Abingdon, UK. | Director/Board Member | 04.04.2012 |
OrthoSon Ltd.
OrthoSon Ltd. Medical SpecialtiesHealth Technology OrthoSon Ltd. engages in the development of novel medical device for the treatment of chronic low back pain. The company was founded by Constantin Coussios and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - |
Ehemalige bekannte Positionen von Glyn Owain Edwards
Unternehmen | Position | Ende |
---|---|---|
Discuva Ltd.
Discuva Ltd. Pharmaceuticals: MajorHealth Technology Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 05.06.2020 |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Chief Executive Officer | 01.06.2012 |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Chief Executive Officer | 01.03.2011 |
Antisoma Research Ltd. | Chief Executive Officer | 01.01.2011 |
░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Ausbildung von Glyn Owain Edwards
University of Bristol | Undergraduate Degree |
London Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SUMMIT THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 10 |
---|---|
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Antisoma Research Ltd. | |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Commercial Services |
The National Cancer Research Institute
The National Cancer Research Institute Miscellaneous Commercial ServicesCommercial Services The National Cancer Research Institute (NCRI) is an organization that focuses on advancing cancer research with the input of cancer patients and carers. The non-profit company is based in London, UK. The British company collects research funding data to understand how money is distributed across various areas of research and identify any gaps. NCRI is creating a research-ready workforce, strengthening the retention of early career researchers and facilitating the early interaction of clinical and preclinical researchers. The company aims to deliver better outcomes for those affected by cancer by identifying gaps in research and addressing them. | Commercial Services |
Discuva Ltd.
Discuva Ltd. Pharmaceuticals: MajorHealth Technology Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
OxSonics Ltd.
OxSonics Ltd. Hospital/Nursing ManagementHealth Services OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom. | Health Services |
Therapeutic Antibodies Ltd. | |
Summit (Oxford) Ltd.
Summit (Oxford) Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2019, Summit (Oxford) Ltd. is a subsidiary of Summit Therapeutics, Inc. that engages in the discovery and development of novel drugs. The private company is based in Abingdon, UK. | Health Technology |
OrthoSon Ltd.
OrthoSon Ltd. Medical SpecialtiesHealth Technology OrthoSon Ltd. engages in the development of novel medical device for the treatment of chronic low back pain. The company was founded by Constantin Coussios and is headquartered in Oxford, the United Kingdom. | Health Technology |